DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-11

Study Completion Date

2024-03-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1.1. Primary Objectives

* To determine if MRI DWIBS can accurately identify suspicious lesions previously categorized on mammography and sonography as potentially malignant.
* We will also validate whether DWIBS-MRI ADC values can be used to accurately differentiate benign from malignant lesions. Additionally, because it is not known whether tumor type or growth rate (Ki67 values) will affect our results, we will include these parameters in our analysis.
* Once we validate the use of DWIBS-MRI ADC values to determine malignancy, can we establish an ADC threshold value to decrease the number of false positive biopsies that are performed while still maintaining a zero false negative rate?
* This study will also assess the correlation between ADC values and the Ki-67 proliferative index of malignant lesions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection

NCT02411760

Breast Neoplasms

COMPLETED

Magnetic Resonance Imaging in Patients With Breast Cancer

NCT00610181

Breast Cancer

COMPLETED

Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast Lesions

NCT02529384

Breast Neoplasms DWI

UNKNOWN

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

NCT05042687

Breast Cancer

RECRUITING NA

Advanced Diffusion Tensor MRI for Breast Cancer

NCT04774471

Breast Cancer Breast Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A patient will be eligible for inclusion in this study if she meets all of the following criteria:

1. \>30 years of age
2. Genetic Female
3. Suspected diagnosis of BIRADS 4 or BIRADS 5 masses and/or asymmetries greater than 1 centimeter based on standard 2D/3D mammogram and ultrasound imaging.

Exclusion Criteria

* A patient is ineligible for inclusion in this study if she meets any of the following criteria:

1. Prior biopsy of suspicious lesion
2. Breast implants
3. Prior history of breast cancer
4. Patient has a pacemaker
5. Contraindications to use of MRI imaging (metal implants, etc.)
6. Woman pregnant or lactating
7. Calcifications as only findings present for a suspicious lesion

Minimum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes